Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Patient-Reported Outcomes Available at Point-of-Care

By HospiMedica International staff writers
Posted on 29 Dec 2014
A new partnership enables oncology providers to easily gather and view patient reported outcome (PRO) data at the point of care (POC). More...


The integration of the Vector Oncology (Memphis, TN, USA) Patient Care Monitor and the Flatiron Health (New York, NY, USA) OncoEMR cloud-based electronic medical record (EMR) is intended to provide oncology care providers with additional insights needed to support quality of life and alleviate symptom burden for cancer patients. The Patient Care Monitor is a web-based technology platform that collects data from patients at the POC, including 86 physical symptoms across treatment side effects, impairment, acute distress, and despair and depression.

Flatiron Health and Vector Oncology will also collaborate on various studies involving health outcomes and economic endpoints in support of clinical research efforts and real-world evidence generation. In addition, Lee Schwartzberg, MD, president and chief medical officer for Vector Oncology, will serve as a medical advisor to Flatiron Health, thus helping to leverage PRO data with Flatiron's EMR platform in order to merge technology in the support of the oncology community and achieve meaningful improvements in cancer care.

“The integration of Flatiron's OncoEMR with our Patient Care Monitor will create an unmatched source of real world clinical and patient reported outcomes intelligence to improve the quality of cancer care and demonstrate the effectiveness and value of treatments,” said Mike Choukas, CEO of Vector Oncology.

“We are excited to partner with Vector Oncology, as we share a similar goal of leveraging technology to improve the quality of cancer care for patients,” said Nat Turner, co-founder and CEO of Flatiron Health. “This alliance will enable us to further support oncology providers with additional insights at the point of care.”

Related Links:

Vector Oncology
Flatiron Health



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.